Lateral Flow Assay (LFA) validation and manufacturing
ID: HCKBG-2025-00447Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

Original Source

https://sam.gov/opp/05082b6f019b4c09a94d31c66d42b7ca/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified sources for the validation and manufacturing of lateral flow assays (LFA) aimed at diagnosing HIV antiretroviral usage in point-of-care settings. The CDC requires an established medical device company capable of producing 25,000 lateral flow devices, which will be utilized in pre-clinical and clinical studies, with the contractor responsible for adapting the provided technical design to their production pipeline and optimizing test performance. This initiative is part of the broader effort to enhance HIV prevention and treatment strategies, emphasizing the need for rapid and cost-effective assays to monitor drug levels. Interested parties must submit their responses, including organizational details and relevant project experience, to Mark Wirtz at mag8@cdc.gov by January 31, 2025, at 12:00 p.m. EST, as this notice is for market research purposes only and does not constitute a solicitation for proposals.

    Point(s) of Contact
    Mark Wirtz
    mag8@cdc.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Lateral Flow Assay (LFA) validation and manufacturing
    Currently viewing
    Sources Sought
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Buyer not available
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Request for Information (RFI) for Device and Maintenance Services for medical point-of-care molecular disease analyzer.
    Buyer not available
    The Department of Homeland Security, specifically the U.S. Coast Guard (USCG), is issuing a Request for Information (RFI) to explore the market for medical point-of-care molecular disease analyzers, with the intent to replace its aging Cepheid GeneXpert systems. The USCG aims to procure approximately 55 new devices that can test for multiple diseases, including SARS-CoV-2, Influenza A and B, and various bacterial infections, emphasizing the need for FDA approval, high specificity and sensitivity, rapid turnaround times within 60 minutes, and compatibility with electronic health records. This initiative is crucial for enhancing the USCG's medical capabilities and ensuring timely disease detection among personnel. Interested vendors are encouraged to submit their responses by March 25, 2025, and can direct inquiries to Jamison Harned at jamison.w.harned@uscg.mil or by phone at 571-613-5151.
    Brand Name or Equivalent of Bio-Rad Evolis and Geenius serological automated analyzers with UPS backup systems for the Walter Reed Army Institute of Research (WRAIR)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking sources for the procurement of Bio-Rad Evolis and Geenius serological automated analyzers, along with uninterrupted power supply (UPS) backup systems, for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. The requirement includes high-volume HIV testing and confirmation capabilities, with specifications for independent processing systems, automated sample integrity detection, and compatibility with existing laboratory systems, all while adhering to FDA regulations for HIV screening. This initiative is crucial for enhancing infectious disease management among U.S. service members, particularly concerning HIV and hepatitis C. Interested vendors should contact Brenda Mena at brenda.i.mena.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further details, as the contract is expected to span from September 30, 2025, to September 29, 2030.
    Various Roche Cobas® 5800 Rental Reagent Package with Reagents, Controls, Consumables and Maintenance
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure a rental reagent package for the Roche Cobas® 5800 diagnostic system, which includes essential reagents, controls, consumables, and maintenance services. This procurement aims to enhance the capabilities of healthcare facilities in conducting reliable and efficient testing for infectious diseases, particularly for HBV, HCV, and HIV, as outlined in the accompanying catalog of medical kits and components. The extensive range of products available is crucial for public health initiatives, ensuring timely and accurate diagnostics. Interested vendors can reach out to Shasheshe Goolsby at shasheshe.goolsby@nih.gov or call 301-827-4879 for further details regarding this presolicitation opportunity.
    Synopsis of Proposed Contract Action
    Buyer not available
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole-source contract to Certified Technical Experts, Inc. for the development, enhancement, maintenance, and interoperability of medical coding systems. This procurement is critical as it ensures the effective management and application of medical coding, which is essential for healthcare data processing and interoperability. Interested parties are invited to respond within 15 days of the notice's issuance to express their capability for competitive procurement, with quotations due by COB March 20, 2025. For further inquiries, interested vendors can contact David Santimaw at zgm2@cdc.gov or Arianna Williams at xsm2@cdc.gov.
    Q301-- Five (5) Full-Time Equivalent Certified Medical Technologists
    Buyer not available
    The Department of Veterans Affairs is seeking to procure the services of five full-time certified Medical Technologists to support the Public Health National Program Office. These professionals will be responsible for performing high-complexity molecular laboratory testing and laboratory information management services, which are critical for the nation's biodefense strategy and public health preparedness, particularly in diagnosing emerging pathogens and high-consequence infections. Interested vendors must respond with their company details and capabilities by March 13, 2025, with a preference for submissions from service-disabled veteran-owned and veteran-owned small businesses. For further inquiries, potential respondents can contact Contracting Officer Larry Facio at Larry.Facio@va.gov or by phone at 916-923-4553.
    6550--VISN 19 Compatible Cepheid Reagents and Consumables
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking potential suppliers for compatible Cepheid reagents and consumables through a Sources Sought Notice issued by the Network Contracting Office 19. The procurement aims to identify suppliers of molecular diagnostic test kits for various pathogens, including Methicillin-Resistant Staphylococcus aureus, Norovirus, and Covid, to enhance the diagnostic capabilities of the VA's Pathology and Laboratory Services across multiple clinical laboratory locations. This initiative underscores the VA's commitment to improving healthcare for veterans while adhering to federal procurement standards. Interested vendors are encouraged to submit their capabilities, business size status, and compliance details by March 13, 2025, at 9 AM MT, with inquiries directed to Contract Specialist Tania Urenda at tania.urenda@va.gov or by phone at 303-712-5730.
    6630--BD Viper
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors for the BD Viper LT System, aimed at facilitating Onclarity HPV Self-Collect Testing. This Sources Sought Notice, identified by solicitation number 36C25625Q0578, requests information on vendors' capabilities to provide an in vitro diagnostic testing system capable of detecting DNA from 14 high-risk HPV types associated with cervical cancer, with specific requirements for automation in sample preparation, DNA extraction, and result interpretation, targeting a throughput of 90-120 results per day. The procurement is critical for enhancing cervical cancer screening processes, and vendors must submit detailed responses regarding their capabilities, socio-economic status, and estimated pricing by March 7, 2025. For further inquiries, interested parties can contact Contract Supervisor Troy L. Davis at troy.davis@va.gov or by phone at 713-791-1414 ext. 27978.
    Monoclonal Antibodies and Viral Recombinant Antigens
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking suppliers for monoclonal antibodies and viral recombinant antigens, as outlined in a Special Notice. This procurement aims to acquire in vitro diagnostic substances, reagents, test kits, and sets, which are critical for various medical and research applications within the military health system. The place of performance for this contract will be in Maryland, United States, and interested vendors can reach out to Shelley Wallace at shelley.a.wallace2.civ@health.mil or Tonya Kreps at tonya.r.kreps.civ@health.mil for further information. The notice does not specify a funding amount or key deadlines, but interested parties are encouraged to inquire for additional details.